Target
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI
Ligand
BDBM36537
Substrate
n/a
Meas. Tech.
Jump dilution assay
pH
7.5±n/a
Temperature
298.15±n/a K
Ki
18.9±1.1 nM
Comments
extracted
Citation
 Tonge, PPan, P Pyridone FabI inhibitors and uses thereof US Patent  US10071965 Publication Date 9/11/2018 
Target
Name:
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI
Synonyms:
Enoyl-ACP Reductase (FabI) | Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI | FABI_STAAR | NADPH-dependent enoyl-ACP reductase | fabI | trans-2-enoyl-[acyl carrier protein] reductase
Type:
Enzyme
Mol. Mass.:
27989.00
Organism:
Staphylococcus aureus
Description:
Q6GI75
Residue:
256
Sequence:
MLNLENKTYVIMGIANKRSIAFGVAKVLDQLGAKLVFTYRKERSRKELEKLLEQLNQPEAHLYQIDVQSDEEVINGFEQIGKDVGNIDGVYHSIAFANMEDLRGRFSETSREGFLLAQDISSYSLTIVAHEAKKLMPEGGSIVATTYLGGEFAVQNYNVMGVAKASLEANVKYLALDLGPDNIRVNAISAGPIRTLSAKGVGGFNTILKEIEERAPLKRNVDQVEVGKTAAYLLSDLSSGVTGENIHVDSGFHAIK
  
Inhibitor
Name:
BDBM36537
Synonyms:
2-phenoxylphenol | PT51 | US10071965, Compound PT51
Type:
Small organic molecule
Emp. Form.:
C12H10O2
Mol. Mass.:
186.2066
SMILES:
Oc1ccccc1Oc1ccccc1
Structure:
Search PDB for entries with ligand similarity: